First Turn Management »

Newamsterdam Pharma Co Nv shares owned by First Turn Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 717k 28.44
2025-06-30 $9.4M 521k 18.11

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Bain Capital Life Sciences Investors
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Viking Global Investors
FMR
Deerfield Management Company
Jennison Associates
Wellington Management Company
Polar Capital Holdings
Medicxi Ventures Management
Adage Capital Partners GP
Cormorant Asset Management
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv